Exploring the Potent Anticancer Activity of Essential Oils and Their Bioactive Compounds: Mechanisms and Prospects

Fatouma Mohamed Abdoul-Latif1, Ayoub Ainane2, Ibrahim Houmed Aboubaker3

  • 1Medicinal Research Institute, Center for Studies and Research of Djibouti, IRM-CERD, Route de l'Aéroport, Haramous, Djibouti City P.O. Box 486, Djibouti.

Insights

Essential oils (EOs) show potent anticancer activity, but their mechanisms are not fully understood. This review synthesizes research on EO anticancer actions and explores future drug development potential.

Area of Science:

  • Natural Product Chemistry
  • Oncology
  • Pharmacology

Background:

  • Cancer remains a leading global cause of mortality.
  • Natural substances, particularly plant-derived essential oils (EOs), exhibit promising anti-tumor properties.
  • Despite evidence of efficacy, the precise anticancer mechanisms of EOs are not well-defined.

Purpose of the Study:

  • To synthesize recent findings on the anticancer mechanisms of essential oils and their bioactive compounds.
  • To review in vitro and in vivo studies investigating EO anti-tumor effects.
  • To explore future research directions and potential applications in cancer drug development.

Main Methods:

  • Literature review of recent studies on essential oils and cancer.
  • Analysis of in vitro and in vivo experimental data on EO anticancer activity.
  • Synthesis of current understanding of EO mechanisms of action.

Main Results:

  • Essential oils and their constituents demonstrate significant anticancer activities in various studies.
  • Understanding the specific molecular targets and pathways of EOs requires further investigation.
  • Challenges remain in achieving pharmacodynamic specificity and developing effective EO formulations for clinical use.

Conclusions:

  • Essential oils represent a promising area for novel cancer therapeutics.
  • Further research is crucial to elucidate mechanisms, optimize delivery, and ensure safety for clinical translation.
  • Continued investigation holds potential for developing new, natural-based cancer drugs.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
314
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K